Sino Biopharmaceutical Limited

Sino Biopharmaceutical : World's First Phase III Clinical Data for a HER2 Bispecific ADC Released! SBP Group's Innovative Breast Cancer Therapy TQB2102 Presented as an LBA at ESMO 2026
www.marketscreener.com · 23 Oct 2026
Sino Biopharmaceutical Limited Estimates – TRADEGATE:SMZ1
TradingView · 23 Oct 2026
Bank of America raises Sino Biopharm stock target to HKD 7.40
ad-hoc-news.de · 20 Oct 2026
Bank of America raises target for Sino Biopharm stock to HKD 7.40
ad-hoc-news.de · 17 Oct 2026
Sino Biopharm completed enrollment: Sino Biopharmaceutical stock is 33.08 percent below its high
AD HOC NEWS · 13 Oct 2026
Sino Biopharmaceutical Partners with German Drugmaker STADA to Target Global PD-1 Biosimilar Market
finance.biggo.com · 29 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.